NCT06077539View on ClinicalTrials.gov

Dexmedetomidine Versus Ketamine Versus Magnesium Sulfate for the Prevention of Emergence Agitation Following Sevoflurane Induced Anesthesia in Cardiac Catheterization in Pediatrics

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

April 15, 2024

Study Completion Date

May 1, 2024

Conditions
Anesthesia Emergence Delirium
Interventions
DRUG

Dexmedetomidine

a selective a-2 adrenoceptor agonist, has sedative, analgesic, and anxiolytic effects.

DRUG

Ketamine

NMDA (N-methyl-D-aspartate) receptor antagonist

DRUG

Magnesium

NMDA (N-methyl-D-aspartate) receptor antagonist

OTHER

normal saline 0.9% NaCL

saline will be given as bolus over 10 min then will be infused as maintenance by the same rate of the other groups

Trial Locations (1)

02

RECRUITING

Amany Hassan Saleh, Giza

All Listed Sponsors
lead

Cairo University

OTHER